Free Trial

Fulgent Genetics (FLGT) SEC Filings & 10K Form

Fulgent Genetics logo
$17.87 +0.92 (+5.43%)
(As of 11/22/2024 ET)

Recent Fulgent Genetics SEC Filings

DateFilerForm TypeView
11/08/2024
6:17 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:10 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:30 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:20 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:21 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
6:36 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
6:37 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:33 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:34 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
7:22 PM
Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
6:38 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
6:09 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:27 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
3:28 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
3:29 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:22 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:22 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:04 PM
Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:05 PM
Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
5:06 PM
Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:29 PM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:22 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:34 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
6:05 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
3:35 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:07 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:26 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:28 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:12 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:08 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
02/27/2024
5:50 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:52 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:55 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:48 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:26 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:01 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:39 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:49 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
8:43 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
5:00 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:47 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:54 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:13 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FLGT) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners